Association Study Indicates a Protective Role of Phosphatidylinositol-4-Phosphate-5-Kinase against Tardive Dyskinesia
Author(s) -
Olga Fedorenko,
A.J.M. Loonen,
F. Lang,
Valentina A. Toshchakova,
E.G. Boyarko,
A. Semke,
Н. А. Бохан,
Н. В. Говорин,
Lyubomir I. Aftanas,
Svetlana А. Ivanova
Publication year - 2014
Publication title -
the international journal of neuropsychopharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.897
H-Index - 107
eISSN - 1469-5111
pISSN - 1461-1457
DOI - 10.1093/ijnp/pyu098
Subject(s) - tardive dyskinesia , dyskinesia , neurotoxicity , single nucleotide polymorphism , antipsychotic , medicine , schizophrenia (object oriented programming) , pharmacology , psychiatry , genetics , biology , gene , toxicity , genotype , parkinson's disease , disease
Tardive dyskinesia is a disorder characterized by involuntary muscle movements that occur as a complication of long-term treatment with antipsychotic drugs. It has been suggested to be related to a malfunctioning of the indirect pathway of the motor part of the cortical-striatal-thalamic-cortical circuit, which may be caused by oxidative stress-induced neurotoxicity.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom